Galectin Therapeutics ($GALT) Insider Trading & Smart Money Activity
Galectin Therapeutics Inc. ($GALT) has 10 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($262.96K), net -$262.96K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$262.96K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
GALT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $262.96K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All GALT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Harold Shlevin | Sell (Option exercise) | 22.27K sh | -6.8% | -29.8% | — | |||||
| Insider | Harold Shlevin | Buy (Option exercise) | 22.27K sh | $27.39K | -6.8% | -29.8% | — | ||||
| Insider | Khurram JamilChief Medical Officer | Sell (Open-market sale) 10b5-1 | 47.47K sh | $239.23K | -6.8% | -29.8% | Read | ||||
| Insider | Khurram JamilChief Medical Officer | Buy (Option exercise) | 47.47K sh | $118.67K | -6.8% | -29.8% | — | ||||
| Insider | Harold Shlevin | Buy (Option exercise) | 7.73K sh | $9.51K | -7.2% | -32.3% | Read | ||||
| Insider | Khurram JamilChief Medical Officer | Sell (Option exercise) | 2.53K sh | -7.2% | -32.3% | Read | |||||
| Insider | Khurram JamilChief Medical Officer | Buy (Option exercise) | 4.57K sh | $10.81K | -7.2% | -32.3% | Read | ||||
| Insider | Khurram JamilChief Medical Officer | Sell (Open-market sale) 10b5-1 | 7.56K sh | $23.73K | +48.7% | +10.6% | — | ||||
| Insider | Khurram JamilChief Medical Officer | Sell (Option exercise) | 7.56K sh | +48.7% | +10.6% | — | |||||
| Insider | Khurram JamilChief Medical Officer | Buy (Option exercise) | 7.56K sh | $9.30K | +48.7% | +10.6% | Read | ||||
| Analyst | HC Wainwright | Reiterates to buy | PT $11 | +48.7% | +10.6% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $11 | +48.7% | +10.6% | Read |
1W / 1M / 6M = how GALT moved from the trade or filing date.
Insider trading in GALT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Khurram Jamil | Chief Medical Officer | 7 | -$262.96K | Jun 29, 2026 | |
| Harold Shlevin | 3 | — | Jun 29, 2026 |
Analyst ratings on GALT
Frequently asked questions
Are GALT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $262.96K, a net -$262.96K.
What is the latest insider trade in GALT?
Harold Shlevin filed a sell (option exercise) of 22.27K sh on Jun 29, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.